3 results
Approved WMOCompleted
Pilot study:Primary objective: feasibilitySecondary objectives: response rate, time to progression, overall survival and quality of life.Phase II study:Primary objective: efficacy.Secondary objectives: toxicity, especially grade 3 and 4 toxicities,…
Approved WMOCompleted
The purpose of this study is to evaluate how safe telisotuzumab vedotin is and how telisotuzumab vedotin is tolerated as monotherapy and in combination with osimertinib.
Approved WMOPending
Primary Objective: To assess the safety of long-term administration of KVD900 in adolescent and adult patients with HAE type I or II.Secondary Objectives: • To assess the long-term efficacy of KVD900 in the treatment of attacks in adolescent and…